The volatility impacting the All Ordinaries Index (ASX: XAO) since the end of 2021 has been painful for some companies.

For investors, there can be a danger in trying to 'catch a falling knife'. That's the concept of investing in a business where the share price is falling, the investor buys in, and the share price keeps falling. A share price that falls from $100 to $20 can still halve again to $10.

However, finding businesses that are down heavily but are still expected to grow over the long term could be a good opportunistic strategy.

Here's why the ASX All Ords shares in this article could be bargain buys after hitting 52-week lows.

Adore Beauty Group Ltd (ASX: ABY)

Adore Beauty claims to be the leading online retailer of beauty products in Australia.

But, the Adore Beauty share price hasn't seen a beautiful performance over the last 12 months. It's down by around 60%.

It's understandable that the ASX All Ords share has gone backwards a bit, considering interest rates have shot higher. That logic applies to most All Ords ASX shares that don't actually benefit from higher interest rates, because higher interest rates act like gravity on valuations, pulling down asset prices.

But, the company is also suffering from the impact of reduced online shopping now that lockdowns are in the past and COVID impacts are fading.

For example, in the FY23 half-year result, the company reported that revenue dropped 17% to $93.6 million and active customers declined 9% to 801,000. The earnings before interest, tax, depreciation and amortisation (EBITDA) margin was just 0.4%, reflecting "lower operating leverage, inflationary pressures and phased investments in key initiatives".

But, February 2023 sales were up 3.7%. I think the future is positive, with cost optimisation and margin improvement which could help profit in future years. The EBITDA margin is expected to improve, and I think more shoppers will buy online in the coming years.

FINEOS Corporation Holdings PLC (ASX: FCL)

FINEOS describes itself as a leading provider of core systems for life, accident and health insurance carriers globally. It works with seven of the 10 largest group life and health carriers in the United States as well as six of the 10 largest life and health carriers in Australia.

Over the past year, the FINEOS share price has dropped around 50%.

The ASX All Ord share's FY23 half-year results also saw some financial numbers go backwards.

While subscription revenue went up 18.4% to €29.9 million, total revenue dropped 6% to €61.5 million, with North America representing 78.3% of total revenue. It made an EBITDA loss of €2.6 million, down from a profit of €6.5 million in the FY22 first half.

The statutory net loss was €14.6 million.

While the company advised that sales deal closing had been "slower" than it would like, it did say the pipeline is "very strong". The business is investing in automation to achieve further efficiencies across the business.

Management believes that customers will invest in extending their use of the FINEOS platform to enhance their business operations by replacing legacy core systems. It expects to achieve positive free cash flow in the second half of FY24.

Bubs Australia Ltd (ASX: BUB)

The Bubs share price has dropped by more than 50% in the past six months, despite the infant formula business making progress on its global growth plans.

In the first half of FY23, gross revenue dropped 1%, though infant formula revenue jumped 44%.

Bubs said that its inventory provision balance was driven by "volatile trading conditions and slower-than-expected consumer offtake in key markets."

The ASX All Ords share recorded an EBITDA statutory loss of $44.4 million.

Bubs claims to be the number one goat formula brand in both Australia and the US.

US and 'other international' sales increased 63% year over year, with the US contributing 31% of first-half group revenue.

China sales were reflected by lockdowns and channel disruption.

Bubs expects the growth rate in China to improve thanks to the easing of restrictions and borders reopening, with "momentum building in the fourth quarter." It also sees the US as a key export market for the long term.

Management is confident it has sufficient capital to realise its growth ambitions. It had cash of $51.4 million on its balance sheet as at 31 December 2022.

The post Bargain buys? 3 ASX All Ords shares trading at 52-week lows right now appeared first on The Motley Fool Australia.

A number of results have hit the All Ords today. Some have gone down well with investors, other have had them hitting the sell button.

Three results that are in the latter category are summarised below. Here's why investors are selling these ASX All Ords shares:

CogState Limited (ASX: CGS)

The CogState share price is down 20% to $1.30. This morning, this ASX All Ords neuroscience technology company revealed that it expects to report a 12% decline in first-half clinical trials revenue to $17.1 million and breakeven profit before tax.

Management advised that its revenue and profit were impacted by a slower than expected enrolment of patients by pharmaceutical companies in a small number of their large Alzheimer's trials. More of the same is expected in the second-half, with management guiding to a full-year revenue decline of 6% to 9%.

Fineos Corporation Holdings PLC (ASX: FCL)

The Fineos share price has crashed 16% to $1.65. Investors have been selling the shares of this leading provider of core systems for employee benefits and life, accident and health insurance after its first-half loss widened.

Fineos posted an 18.4% increase in subscription revenue to 29.9 million euros and a 14.7% lift in annual recurring revenue (ARR). However, overall revenue was down 6% on the prior corresponding period.

On the bottom line, the ASX All Ords company posted a loss after tax of 14.6 million euros, up from a loss of 4.6 million euros a year earlier.

Resimac Group Ltd (ASX: RMC)

The Resimac share price is down 9% to $1.06. This morning, this residential mortgage lender released its half-year results and reported a 30% decline in normalised net profit after tax to $37.5 million.

This was driven by a sharp reduction in home loan settlements compared to the prior corresponding period due to the impact of inflation and rising interest rates on household cost-of-living.

Management warned that there are no signs of relief in rising interest rates and inflationary pressures this year, which is likely to mean a tough second half. However, it remains positive on the medium term outlook.

The post 3 ASX All Ord shares being hammered on earnings today appeared first on The Motley Fool Australia.

If your risk profile allows it, having a little exposure to the small end of town could be a good thing for a portfolio.

That's because of the potentially strong returns that are on offer with small cap ASX shares.

But which ones could be buys? Two that Goldman Sachs rates as buys are listed below. Here's what it is saying about them:

FINEOS Corporation Holdings PLC (ASX: FCL)

The first small cap ASX share to look at is Fineos, which is a provider of core systems for life, accident, and health insurance carriers globally. It has 7 of the 10 largest group life and health carriers in the US, as well as a 70% market share of group insurance in Australia.

Goldman is very positive on the company and has a buy rating and $2.40 price target on its shares. It commented:

Recent industry data points and commentary suggest that demand conditions are normalizing into 2023, with easing wage pressures increasing confidence in FCL's cash break-even trajectory (we now see upside to consensus earnings across FY23-25E). Separately, FCL's closest US comp Duck Creek was taken out for ~2-3x FCL's trading multiple, providing valuation support for the sector.

Maas Group Holdings Ltd (ASX: MGH)

Another small cap ASX share to consider buying is Maas. It is a construction material, equipment and service provider.

Goldman believes that it could be a small cap to buy and has a buy rating and $4.20 price target on its shares. The broker is positive thanks to Maas' ongoing transition, which it believes this will underpin higher quality earnings. It explained:

We believe MGH is in a transition phase and will see higher quality real estate income become the largest source of earnings in the next 3-5 years. We believe the market is mispricing how MGH's civil and construction capabilities support the property development business to deliver best-in-class margins and asset turnover. In our view the value created through the development of quality annuity revenue from Build-to-Rent (BTR), Land Lease (potentially generating a 4.5x ROIC annuity income stream) and commercial real estate projects could re-rate the stock.

The post Goldman Sachs says these ASX small cap shares are buy with major upside potential appeared first on The Motley Fool Australia.

The FINEOS Corporation Holdings PLC (ASX: FCL) share price is heavily in the red today after the insurance software company released its earnings card for FY22.

Shares in the ASX tech company are trading down 6.14% at $1.53 apiece at the time of writing. They previously touched a high of $1.68 shortly after the market opened this morning.

Let's go over what the company announced.

What did Fineos report?

• Total revenue up 17.5% year-over-year (YoY) to €$127.2 million (A$183.38 million)
• Gross profit up 15.3% YoY to €$83 million (A$119.62 million)
• Earnings before interest, tax, depreciation, and amortisation (EBITDA) up 28.8% YoY to €$6.7 million (A$9.66 million)
• Annual recurring revenue (ARR) up 23.4% YoY to €$56.4 million (A$81.27 million)
• Statutory net loss after tax of €$26 million (A$37.47 million)

Fineos advised that it outperformed previous guidance for its subscription revenues, which grew by 34.3% to A$77.52 million and contributed significantly to its top and bottom lines. The organic growth of its services was stated to be 33.5%.

Fineos integrated several acquisitions into the business in FY22, including Spraoi's suite of machine learning and artificial intelligence products. These integrations helped to expand revenues through cross-selling opportunities and inflated the company's sales pipeline for FY23.

What else happened in FY22?

The company's balance sheet strengthened through an influx of cash totalling A$63.84 million, before costs, from its share placement and purchase plans.

Fineos also said that its dominant North American operating segment grew to contribute more to the company's top line, with total contribution growing from 73% to 79% of revenue.

Its headcount remained more or less the same, with 1,075 staff members and contractors. This is expected to stay the same in FY23.

What did management say?

Fineos founder and CEO Michael Kelly said:

FY22 has seen yet another year of strong growth across the key metrics we benchmark our business against, underpinned by our delivery on strategy.

Importantly, we achieved or exceeded the guidance we provided to the market even with the incredibly challenging operating environment faced by most businesses.

I would like to thank all our team for their continued dedication and support that enabled FINEOS to achieve several significant strategic milestones over the past year.

What's next?

Fineos expects revenue for FY23 to fall within the guidance range of A$194.59 million and A$201.80 million, supported by a pipeline it built in FY22 through integrating its acquisitions into its operations.

More broadly, the company notes that it has a positive cash balance with no debt and that its trajectory means it is likely to achieve positive free cash flow in FY24.

Fineos share price snapshot

The Fineos share price is down 66.8% year to date. This is severely underperforming the S&P/ASX 200 Index (ASX: XJO), which is 7.67% lower over the same period.

The company's market capitalisation is $488 million from today's recent price action.

The post Fineos share price sinks 6% on $37.47 million loss appeared first on The Motley Fool Australia.

The Fineos Corporation Holdings PLC (ASX: FCL) share price is rising during late afternoon trade on Thursday.

This comes after the insurance software company announced its fourth quarter results to the market.

At the time of writing, Fineos shares are swapping hands at $1.715, up 6.52%.

What did Fineos report for Q4 FY22?

Here's a brief recap of how the company performed for the 3 months that ended 30 June 2022.

• Cash receipts from customers up 45% year-on-year to €32.9 million ($A48.04 million)
• Headcount up 1% to 1,075 since 30 June 2021
• High product consulting employee utilisation rate of 89% for FY22
• Cash payments from operating activities of €32.4 million (A$47.32 million), up 12% quarter on quarter
• Closing cash balance of €44.3 million ($A64.70 million) and no debt

What happened during the quarter?

For the final quarter of FY22, Fineos recorded customer cash receipts of €32.9 million ($A48.04 million). This reflected a 45% increase over the prior corresponding period, underpinned by strong revenue growth and the ongoing transition of customers to subscription agreements.

Subsequently, this reaffirms the company's FY22 revenue guidance of between €125 million to €130 million (A$182.56 million to A$189.87 million) and subscription revenue growth of at least 30%.

Furthermore, headcount decreased by 0.5% to 1,075 for the quarter but lifted by 1% during FY22. This is expected to remain stable at the current level in FY23.

Capitalised R&D costs for the quarter were down 2% to €6.8 million (A$9.93 million) and up 3% to €25.8 million ($37.67 million) for FY22.

Uncapitalised R&D costs continued to increase in line with Fineos' growth strategy and focus on product development.

What did management say?

Fineos founder & CEO, Michael Kelly commented on the company's performance:

The fourth quarter saw the company continue to deliver on our growth strategy, with strong growth in customer cash receipts and subscription revenue underpinning the reaffirmation of previous guidance provided for FY22.

We finished the quarter with over €44 million in cash and no debt, providing a strong capital position that supports our organic growth plans. With the business continuing its growth trajectory and cash flows building, we are on track to achieve a positive free cash flow position in FY24.

Fineos share price review

Since the start of 2022, the Fineos share price has declined by more than 60%.

Strong volatility on the ASX and a gloomy economic outlook appears to have weighed down the company's shares this year.

Based on today's share price, Fineos presides a market capitalisation of around $530.18 million.

The post 'On track': Fineos share price climbs 6% on strong quarterly appeared first on The Motley Fool Australia.

The insurance industry software provider's shares rose 15% to $1.61.

This means the Fineos share price is now up 24% since this time last week.

Why is the Fineos share price charging higher?

Investors have been bidding the Fineos share price higher following a rebound in the tech sector and some positive broker notes.

In respect to the former, the S&P/ASX All Technology Index rose over 2% on Tuesday after investor sentiment improved in the sector.

As for the latter, both Goldman Sachs and Macquarie have been talking positively about Fineos over the last week.

While Goldman Sachs only initiated coverage on the company's shares with a neutral rating, its price target of $1.65 is still higher than where its shares are trading even after these strong recent gains.

Goldman's analysts "see Fineos as well positioned to benefit from the long-term structural tailwinds of insurance industry digitisation and shift to cloud software."

Over at Macquarie, its team are even more positive. Last week the broker put an outperform rating and $2.89 price target on the company's shares. This implies over 80% upside for the Fineos share price from current levels over the next 12 months.

Macquarie believes that Fineos will outperform its peers in respect to software revenue growth. Yet, despite this, it notes that the company's shares still trade at a large discount to them.

The post Why did the Fineos share price roar 15% higher today? appeared first on The Motley Fool Australia.

The All Ordinaries Index (ASX: XAO) closed almost 2% higher today, but two ASX tech shares outperformed the index.

The All Ords Index climbed 1.94% today to 6,893.6 points. For perspective, the S&P/ASX 200 Index (ASX: XJO) also finished 1.94% in the green.

So let's take a look at which technology companies surged today.

Fineos Corporation Holdings (ASX: FCL)

The Fineos Corporation Holdings share price climbed 14.56% today. Fineos provides software for the life, health, and accident insurance industry. The company's shares appeared to be soaring amid a positive day for ASX technology shares. The S&P/ASX All Technology Index (ASX: XTX) closed 2.62% higher today.

ASX technology shares followed in the footsteps of their US counterparts. The NASDAQ-100 Technology Sector index surged 4.63% on US markets on Friday. On Sunday, US President Joe Biden unveiled a $600 billion infrastructure program. It's aimed at building health systems, energy technology, and information and communication technology networks, CNBC reported.

Fineos reported a 24.4% boost in revenue in the first half of the financial year while gross profit soared 25.6%.

Pointerra Ltd (ASX: 3DP)

Pointerra shares closed 6.38% higher on Monday. The company also appeared to benefit from positive market sentiment for ASX tech shares. In recent news to the market, Pointerra announced two new contracts based in the United States.

Florida Power and Light will deploy the Pointerra3D Answers storm response product. Secondly, NextEra Energy will use Pointerra3D Analytics to support greenfield development and solar energy project sites in the USA. Pointerra reported "continued growth" across the US energy utilities sector.

The post 2 ASX tech shares in the All Ords that soared today appeared first on The Motley Fool Australia.

Among the flurry of earnings flying out this month, you might have missed this ASX All Ordinaries tech share which produced solid top-line growth in the first half.

The Fineos Corporation Holdings PLC (ASX: FCL) share price is finishing the week lower than where it started.

However, shares in the insurance software provider climbed 3.1% today after falling 3% yesterday. This follows the release of Fineos' results for the first half of FY22 on Thursday.

ASX All Ordinaries tech share slips despite productive half

• Revenue up 24.4% to 65.4 million euros (A$102.04 million)
• Annual recurring revenue reached 51.8 million euros, increasing 35.2% year on year
• Gross profit of 42.5 million euros, representing an increase of 25.6% year on year
• Earnings before interest, tax, depreciation, and amortisation (EBITDA) up 103.1% to 6.5 million euros
• Net loss after tax narrowed to 4.6 million euros from 5.1 million euros
• Cash balance as at 31 December 2021 of 48.6 million euros

What else happened during the half?

Investors have lacked an attraction to this ASX All Ordinaries share this week. However, Fineos showed improvement across all of its key metrics in the first half.

According to the release, top-line growth of 24.4% was driven primarily by cross-selling and up-selling to its existing client base. In addition, the company notched up another client win, helping diversify its customer base.

Notably, the largest organic growth was witnessed in Fineos' subscription revenue — increasing 39.5% year on year. Meanwhile, services revenue experienced a 16.4% improvement on the prior corresponding period.

Furthermore, the company highlighted its improvements in de-risking its client concentration during the period. In August 2021, 74% of Fineos' revenue was tied to its top 10 clients. However, that number has been reduced further to less than 61%.

During the half, Fineos raised around $74 million to feed future growth across its operations and expand into new markets.

What's next?

Investors might have been displeased to see Fineos guide towards the lower end of its previously stated revenue range for FY22. For reference, the range provided is between 125 million euros and 130 million euros.

Although, on a positive note, the company reaffirmed expectations for subscription revenue to grow at an annualised rate of around 30%. This was followed up with a disclaimer, noting the guidance is subject to prevailing influences from COVID-19 and the global economy.

How has this ASX All Ordinaries tech share performed?

The Fineos share price has been unable to attract a higher value so far in 2022. In fact, shares in the insurance tech provider have slumped 27% since the year kicked off.

To be fair, this is relatively in line with the broader performance across the tech sector. For example, the S&P/ASX All Technology Index (ASX: XTX) is down 23% year to date.

The post This ASX All Ordinaries tech share just delivered 24% revenue growth appeared first on The Motley Fool Australia.

Businesses that are well-liked by multiple brokers could be an opportunity staring investors in the face. But it could also mean that all of those brokers are wrong at the same time.

Multiple analysts have said the below two businesses are ones that could be opportunities:

Credit Corp Group Limited (ASX: CCP)

Credit Corp is a large debt collector that's operating in both Australia and the USA. It also has a lending division in Australia and New Zealand.

The business is currently rated as a buy by at least three different brokers, including Morgans which has a price target on the business of $33.75.

In FY21, Credit Corp saw a near-record investment outlay driven by the purchased debt ledger (PDL) acquisition from Collection House Limited (ASX: CLH) and a return to lending, despite a COVID-induced temporary reduction in PDL supply.

The ASX share said that FY22 started off well, with a record July contracted purchasing pipeline. The month on month charge-off volumes were also starting to grow.

Overall, the FY21 profit was driven by the US performance. Total revenue fell 1%, but ANZ debt buying profit increased 11% to $54.1 million and US debt buying profit more than doubled to $17.7 million. That helped total profit grow 11% to $88.1 million.

In FY22, Credit Corp is expecting to generate net profit after tax of between $85 million to $95 million, with PDL acquisitions of between $200 million to $240 million.

Based on Morgans' numbers, the Credit Corp share price is valued at 22x FY22's estimated earnings.

FINEOS Corp Holdings PLC (ASX: FCL)

FINEOS describes itself as a global company providing software to the employee benefits, life, accident and health industry. It offers clients purpose-built products. One of its offerings is called AdminSuite which takes care of new business, billing, claims, absence and policy administration, which enables "improved operational efficiency, increased effectiveness and excellent customer care."

It's currently rated as a buy by at least three brokers, including Citi, which has a price target on the ASX tech share of $5.22. After a recent capital raising, Citi thinks the company is well funded to put some of the capital to work in its current business, as well as trying to find other potential businesses to buy.

In FY21, FINEOS generated €108.3 million of revenue, up 23.3%. It also saw 23% of gross profit growth to €72 million.

In FY22, the ASX share is expecting revenue to be in the range of €125 million to €130 million, with subscription revenue anticipated to grow by around 30%. It's expecting to be successful with its pipeline of cross-selling and up-selling opportunities with existing clients and new wins.

At the time of the capital raising, FINEOS CEO Michael Kelly said:

Following a strong FY21 result, FINEOS continues to execute on its strategic priorities and invest in further product development and recent acquisition integrations. Our growth expectations for FY22 are underpinned by a pipeline of cross-sell and up-sell opportunities with existing clients in addition to new name opportunities. The equity raising ensures FINEOS has the balance sheet strength and financial flexibility to aggressively pursue those opportunities and accelerate growth.

The post These 2 ASX shares could be good opportunities appeared first on The Motley Fool Australia.

The FINEOS Corporation Holdings PLC (ASX: FCL) share price is gaining upwards momentum today.

Investors are buying shares in the insurance software company with ferocity on Thursday after it released its full-year results for FY21.

At the time of writing, FINEOS shares are up 16% to $4.27. As a result, the software company is again trading around levels witnessed in April this year.

FINEOS share price shines on top line gain

• Revenue up 23.3% to €108.3 million (AUD$175.6 million)
• Annual recurring revenue reached €45.7 million at 30 June 2021
• Gross profit of €72 million representing an increase of 23% from FY20
• Proforma earnings before interest, tax, depreciation, and amortisation (EBITDA) down 49.6% to €7.9 million
• Net Loss after tax widened from €227,183 to €12.485 million

What happened in FY21 for FINEOS

The market is certainly exhibiting excitement for the FINEOS share price following its results today. In fact, trading volume for the day so far is roughly two and a half times its monthly average.

According to its release, the software company achieved total revenue of €108.3 million in the financial year. This represents an increase of 23.3% on FY20. Likewise, subscription revenue surged 48.6% to €40.1 million. Such an increase bodes well for the company, as it grows its portion of revenue that is recurring.

It wasn't by chance that FINEOS managed to up the ante with respect to revenue in FY21. Rather, it was the expansion of its life, accident, and health core systems — reaching over 60 carriers. Intentionally, the United States now accounts for 73% of total revenue, rising from 59% in the previous reporting period.

Furthermore, the successful acquisitions and integrations of Limelight Health and Spraoi during the year contributed to the strong growth. Specifically, Limelight Health added €9.2 million and Spraoi contributed €0.4 million.

Much of this reported growth was from cross-selling and up-selling to FINEOS' existing customer base. Indicating that the company is not purely 'buying revenue' through acquisition, FINEOS reported organic growth of 12.5%.

Another positive for shareholders, the company appears to have marginally de-risked its client concentration. In FY20, ~74% of total revenue was comprised of the top 10 clients. Whereas, in its latest full-year result, this figure has been reduced to 65%.

Finally, losses widened due to acquisition costs — in addition to increased spend on research and development (R&D). Though, this doesn't appear to be weighing on the FINEOS share price today.

What did management say?

Commenting on the result, FINEOS Chief Executive Officer Michael Kelly said:

FINEOS' growth journey continued into 2021 as we grew revenue, clients, headcount and product offering. We're now positioned as the number one player for group employee benefits in the North American market, measured by revenue, by number of clients and by the end-to-end "quote to claim" product that we provide.

Our primary focus was and continues to be increasing our subsription revenues as we grow FINEOS into the global market leading software-as-a-service platform for life, accident, and health insurance.

Additionally, regarding the company's acquisitions during the period, Mr Kelly said:

We are pleased with the revenue growth, specifically our higher margin subscription revenue which grew
by 48.6% to €40.1 million. Within this, organic growth was a strong 32.4% with the balance from the two acquisitions we made during the year (Limelight Health and Spraoi). This year's revenue growth was
attributable to successful client implementations, cloud upgrades and add-on cross sales.

What's next for FINEOS ?

Heading into FY22, the company is guiding for €125 million to €130 million in revenue. Positively, subscription revenue is expected to increase approximately 30%.

FINEOS management mentioned that these growth projections are supported by a robust pipeline of significant cross-sell and up-sell opportunities with existing clients. These are in addition to some fresh client opportunities also being presented.

Meanwhile, the R&D costs aren't expected to decrease for the next year. Instead, R&D expenses will continue as the company integrates its acquisitions and works more on product development.

Additionally, the company will be focused on further cloud upgrades in FY22. In particular, several migrations are slated across the United States and ANZ regions during the year.

FINEOS share price snapshot

Although the FINEOS share price is gleaming green today, the past year does not mimic the same performance. Over the past 12 months, the FINEOS share price has fallen 21.5%. For comparison, the S&P/ASX 200 Index (ASX: XJO) has gained 22.3%.

The post FINEOS (ASX:FCL) share price jumps 15% on solid FY21 result appeared first on The Motley Fool Australia.

The S&P/ASX 300 Index (ASX: XKO) is heading south today, breaking the week's consecutive days in green territory.

At the time of writing, the ASX 300 is down 0.64% to 7,383.5 points.

Here's a summary of which ASX shares are topping the charts today.

FINEOS Corp Holdings PLC (ASX: FCL)

The FINEOS share price is up a mammoth 16.98% to $4.30 following the company's release of its full-year results.

The insurance software company highlighted robust growth, driven by its subscription revenues. In total, FINEOS achieved revenue of €108.3 million (A$175.41 million), up 23.3% on FY20.

The company did not include a dividend payment for the FY21 year.

City Chic Collective Ltd (ASX: CCX)

Another significant mover today is the City Chic share price, up 14.26% to an all-time high of $6.25. The fashion retailer released its full-year results, announcing strong revenue of $258.5 million, up 32.9% on FY20. This was underpinned by online sales growth of $184.6 million, up 49.3%.

No dividend was stated for the second half of the FY21 period.

Blackmores Ltd (ASX: BKL)

Following suit, the Blackmores price is up 11.34% to a 52-week high of $88.84.

The strong rise in Blackmores shares comes as the company provided its full-year results to the market. The health supplements business reported positive numbers despite operating in a changing COVID-19 environment.

The company is set to reward eligible shareholders with a fully-franked dividend payment of 42 cents per share.

And the ASX 300 companies moving the other way?

Appen Ltd (ASX: APX)

Falling heavily is the Appen share price, down a massive 20.77% to $10.95.

The artificial intelligence data services company released its half-year results for the FY21 period, registering disappointing numbers across key metrics. Most notably, Appen's net profit after tax fell 55.1% to US$6.7 million. 

The board decided to maintain its 50% franked interim dividend of 4.5 cents per share.

Link Administration Holdings Ltd (ASX: LNK)

Also in decline is the Link share price, down 12.43% to $4.51.

The administration services company dropped its full-year results to the market, recording losses due to COVID-19 headwinds. In addition, European business and regulatory changes in its Retirement and Superannuation Solutions (RRS) business brought in lower revenues.

Link declared a fully franked dividend of 5.5 cents per share, up 4.5 cents in H1 FY21.

The post Which ASX shares are leading the ASX 300 today? appeared first on The Motley Fool Australia.

There are some really good ASX tech shares out there that are rated as buys by brokers.

Brokers (hopefully) have a good understanding of the merits of the businesses and have given thought to whether, at the current share price, a business is a buy, hold or sell right now.

These two businesses are ones that brokers think are buys in the technology space at the moment:

FINEOS Corporation Holdings PLC (ASX: FCL)

FINEOS is a software provider for the employee benefits and life, accident and health industry. Its technology aims to improve operational efficiency, increase effectiveness and provide excellent customer care.

The 'FINEOS AdminSuite' is designed to manage the modern complex structures and relationships of group and individual insurance processing to optimise the plan, coverage and data management, operational processing and business intelligence.

It's currently rated as a buy by at least three brokers including Macquarie Group Ltd (ASX: MQG). The price target from Macquarie is $4.63, which suggests a potential upside of around 20% over the next 12 months if the broker is right.

Macquarie believes that FINEOS looks good value when looking at its peers, yet the business continues to make good operational progress. The broker thinks that it has a good future.

The ASX tech share is expecting organic subscription revenue growth of 30% for FY21. Management said this demonstrates strong and consistent software as a service (SaaS) revenue growth. Around 71% of its revenue is cloud-based.

It's also looking for strategic bolt on acquisitions to enhance the FINEOS platform, such as Spraoi which is a provider of machine learning capabilities for the employee benefits and life industry.

Temple & Webster Group Ltd (ASX: TPW)

Temple & Webster is an online furniture and homewares business which sells many thousands of products through its website.

It's currently rated as a buy by at least two brokers including Morgan Stanley. The broker has a price target on the ASX tech share of $15.

The broker likes the tailwind for the business of the e-commerce growth story. There also continues to be good demand for the products that Temple & Webster sells. Morgan Stanley thinks that Temple & Webster can become much more profitable in the future.

A few months ago, Temple & Webster told the market that it's going to invest heavily over the next few years to increase its market presence, improve its offering to customers and make the business even more efficient. During this scale-up period, it expects that revenue will increase by "strong double digit" amounts whilst the earnings before interest, tax, depreciation and amortisation (EBITDA) margin would be between 2% to 4%.

But the ASX tech share's management believes that with scale it can achieve operating leverage and higher levels of profitability. That will include improved supplier terms, more repeat customers which will reduce marketing expenses, a slowing of investment in fixed costs and a higher percentage of exclusive products with higher gross profit margins.

Temple & Webster CEO and co-founder Mark Coulter has said:

You only need to look at the US to see how the e-commerce market is playing out, and why we remain bullish about the shift from offline to online. We are at the start of this once in a generation shift, and now is the time to put our foot down to secure market leadership and ensure we are the brand for the next generation of furniture shopper.

The post 2 top ASX tech shares rated as buys by brokers appeared first on The Motley Fool Australia.

Brokers have been looking for ASX shares that might be worth buying for investors. July 2021 could be the month to find these opportunities.

Some businesses have large growth plans for the long-term. If they're able to achieve those goals, then that could lead to pleasing profit growth.

Here are two ASX shares that might be options:

FINEOS Corporation Holdings PLC (ASX: FCL)

FINEOS is a global software business that aims to provide modern customer-centric core software to the employee benefits and life, accident and health industry. It says it helps customers move on from outdated legacy administration systems to its purpose-built, software for new business, billing, claims, absence and policy administration, which improves operational efficiency.

It's currently rated as a buy by brokers at Macquarie Group Ltd (ASX: MQG) with a price target of $4.63. That suggests a potential return of around 17% over the next 12 months if Macquarie is right. The broker believes that FINEOS is capable of more winning more contracts over time and continue increasing in size.

FINEOS says that it's expecting organic subscription revenue growth of 30% for FY21, demonstrating "strong and consistent" software as a service (SaaS) revenue growth. Over 70% of its business is cloud-based revenue. The ASX share is expecting to see an acceleration of cloud adoption in FY22 by its ANZ clients.

A couple of months ago it announced the acquisition of Spraoi, which focuses on the employee benefits and life assurance marketplace. FINEOS said the Spraoi machine learning platform leverages carrier data to learn and generate insights, while the portal infrastructure normalises and improves the customer experience for stakeholders across the value chain.

Baby Bunting Group Ltd (ASX: BBN)

Baby Bunting is one of the faster growing ASX retail shares. It sells a wide range of products for babies and toddlers. The business has a national store network of around 60 stores. It has plans to see a network of over 100 stores around Australia.

Morgans is one of the brokers that likes Baby Bunting with a price target of $6.39, which suggests a potential upside of more than 10% over the next 12 months.

The broker is attracted to the profit growth potential of the business, with the addition of New Zealand expansion an attractive idea.

Baby Bunting said in its half-year result that it has assessed the NZ$450 million New Zealand market opportunity. The ASX share is planning to launch a multi-channel retail proposition with the first store anticipated in FY22 as part of a network plan of at least 10 stores.

The company is experiencing profit margins with greater scale and growth of its private label products. Whilst FY21 half-year revenue grew 16.6%, pro forma earnings before interest, tax, depreciation and amortisation (EBITDA) grew 29.7% and pro forma net profit rose 43.5% to $10.8 million. Total online sales soared 95.9%, making up 19.7% of total sales.

According to Morgans' estimates, the Baby Bunting share price is currently valued at 24x FY22's forecast earnings.

The post Brokers think these 2 top ASX shares are buys in July 2021 appeared first on The Motley Fool Australia.

There are some ASX shares that plenty of brokers like at the moment.

Everyone has a different opinion about each business. But if multiple analysts like the same company then it could be an opportunity:

Steadfast Group Ltd (ASX: SDF)

Steadfast Group says it's the largest general insurance broker network and the largest group of insurance underwriting agencies in Australasia, with growing operations in Asia and Europe.

It has a broker network that get better market access, exclusive products and services through the Steadfast Group. Steadfast has underwriting agencies that designs, develops and provides specialised insurance products and services to brokers inside and outside of Steadfast. Steadfast also has a number of complementary and supporting businesses for insurance like technology, risk, life insurance, reinsurance and lawyers.

Steadfast is currently rated as a buy by at least four brokers, including Credit Suisse which has a price target on Steadfast of $4.60. It noted the recent profit upgrade.

In that upgrade, the ASX share increased its earnings expectations after a "strong" first nine months of FY21 with revenue growth of 7.2% and underlying earnings before interest, tax, depreciation and amortisation (EBITDA) growth of 20.5%.

After good organic growth and accretive acquisitions, Steadfast said that it's expecting underlying net profit after tax (NPAT) to come in a range of $127 million to $132 million – that guidance was increased from a range of $120 million to $127 million. Underlying earnings per share (EPS) is expected to grow by 15% to 20%.   

Steadfast said that strategic partners continue to implement moderate premium price increases.

FINEOS Corporation Holdings PLC (ASX: FCL)

FINEOS is an ASX software share that provides software to the employee benefits and life, accident and health industry. It says that it helps customers upgrade from outdated legacy administration systems to a modern purpose-built, customer-centric product-suite. It enables improved operational efficiency, increased effectiveness and excellent customer care.

It's currently rated as a buy by at least three brokers, including the ones at Macquarie Group Ltd (ASX: MQG) that have a price target of $4.63 on FINEOS. That suggests a possible upside of over 20% over the next 12 months. Macquarie thinks that FINEOS can claim more wins which could help.

In the quarter ending 31 March 2021, it revealed that FY21 total revenue is on track to hit the upper end of its guidance range of $102 million to $105 million and achieve the targeted 30% growth in subscription revenue (before the contribution from the Limelight acquisition).

Since that quarterly update, the ASX share announced the acquisition of Spraoi for an upfront US$4 million and an earnout of up to US$6.6 million. Spraoi is a leading provider of machine learning capabilities for the employee benefits and life industry. It currently has eight clients and achieved US$6 million of revenue in the year to 31 December 2020 and is expected to be earnings accretive to FINEOS, excluding transaction costs, after its first full year.

FINEOS is excited by this acquisition because it gives it immediate opportunities to leverage from its existing client base and product capabilities.

The post 2 ASX shares that multiple brokers really like appeared first on The Motley Fool Australia.

The FINEOS Corporation Holdings PLC (ASX: FCL) share price is retreating today following the company's acquisition announcement.

During early afternoon trade, the insurance software company's shares are exchanging hands for $3.89, down 2.2%. In comparison, the All Ordinaries Index (ASX: XAO) is sitting at 7,364 points, up 0.6% for the day.

FINEOS moves to takeover Spraoi

Investors appear unfazed by the latest announcement by FINEOS, sending its shares lower for the day.

According to its release, FINEOS advised it has entered into a binding agreement with DigIn Technologies LLC (Spraoi) to acquire 100% of Spraoi's issued securities.

Founded in 2017, Spraoi is a leading United States-based company that provides machine learning capabilities for the Employee Benefits and Life industry. The business has 8 clients and generated revenues of US$6 million in the last calendar year.

The transaction will involve an upfront cash payment of US$4 million, and an earnout of up to US$6.6 million over a 3-year period. This is provided that certain revenue targets are achieved within the timeframe. FINEOS will use its existing cash reserves to fund the deal, along with 700,000 share options issued to Spraoi. Once the acquisition is complete, FINEOS anticipates the Spraoi business to be earnings accretive after its first full year.

FINEOS highlighted that Spraoi's products and services are a strategic addition to its current offering. The company foresees immediate opportunities arising through enhancing its machine learning platform capabilities, FINEOS Engage and FINEOS Insight.

Michael Kelly, CEO of FINEOS commented:

The North American employee benefits industry is undergoing tremendous change, which is continually accelerating due to the competitive and regulatory environment, as well as the constant advancement of technology capabilities.

…That combination makes Spraoi a natural addition to the FINEOS team as we continually improve the FINEOS Platform to meet the needs of our clients.

The deal is expected to be completed in the near future subject to customary closing conditions, with integration occurring over the next few months.

About the FINEOS share price

The last 12 months have been positive for FINEOS investors, with its shares posting a 27% increase. Year-to-date performance, however, is a little milder with a modest gain of 5%.

The FINEOS share price reached an all-time high of $5.75 in August 2020, before profit-taking led to its downfall.

Based on today's current price, FINEOS commands a market capitalisation of around $1.1 billion, with roughly 301 million shares outstanding.

The post Why the FINEOS (ASX:FCL) share price is edging lower today appeared first on The Motley Fool Australia.

The FINEOS Corporation Holdings PLC (ASX: FCL) share price is rising after the company announced a new contract for its platform. At the time of writing, the insurance software company's shares are trading at $4.05, up 4.1%.

What's the deal?

Investors are pushing the FINEOS share price higher after digesting the company's latest positive news.

In its announcement, FINEOS advised that it has signed a deal with American Public Life Insurance Company (APL).

Founded in 1945, APL is a leading supplemental insurance company that offers a range of customised products. This includes gap, accident, hospital indemnity, critical illness, cancer, short-term disability, dental and life insurance policies.

Under the agreement, APL will integrate FINEOS' cloud-based platform for new business and underwriting across 8 lines of businesses. The deal will enable APL to streamline and automate quoting, rating, and underwriting processes.

This comes as APL seeks to improve its operational efficiency and roll out 3 new product lines to market. The other 5 existing product lines, expected to be licenced, will also employ the FINEOS cloud-based platform.

FINEOS noted that it had achieved outstanding success since its 2020 go-live date of its FINEOS platform. So far, 10 major carrier clients have adopted the system, including 8 installations and 7 upgrades of the FINEOS Platform for employee benefits.

The Software-as-a-Service (SaaS) contract will run for an initial period of 5 years. FINEOS said it has already factored revenue generation in its most recent guidance update announced on 24 February.

What did management say?

APL president and CEO Jerry Horton touched on the advantages of integrating FINEOS' systems, saying:

By leveraging the FINEOS Platform, we'll be able to improve user experience with a powerful core system that automates processes which have historically been manual for us.

This partnership will enable us to speed up quote turnaround time, improve accuracy, and reduce risk to drive our organization's growth and strategic innovation. Our customers will benefit from better service because of our decision to move from on-prem legacy systems to the cloud-based FINEOS Platform.

FINEOS CEO Michael Kelly went on to add:

We're thrilled about this partnership with APL and look forward to supporting them in achieving their organisational goals.

With the FINEOS Platform for New Business & Underwriting, APL will be able to provide a superior digital user experience at every touchpoint of their quoting, rating, and underwriting processes.

FINEOS share price review

Despite a wobbly start to the year, the FINEOS share price has gained just over 5% year-to-date. However, looking at a broader picture, its shares have risen almost 40% in the past 12 months.

FINEOS has a market capitalisation of around $1.1 billion at the current share price, with 301 million shares on issue.

The post Why the FINEOS (ASX:FCL) share price is climbing this morning appeared first on The Motley Fool Australia.

The share price of ASX insurance software company FINEOS Corporation Holdings PLC (ASX: FCL) has been on the decline recently – dropping almost 30% from its August 52-week high of $5.75 to $4.01 at the time of writing.

It joins a number of ASX technology and software companies that surged to new highs last year but have so far underperformed in 2021.

Company background

FINEOS is a Dublin-based company that develops a suite of software for the life, accident and health insurance industries.

Its platform is capable of supporting insurers in the end-to-end processing of claims, including quotes, billing and payments.  It can also provide insights through reporting and analytics.

FINEOS' customer-centric software automates and streamlines processes for insurance providers and aims to be an all-in-one replacement for legacy insurance administration platforms.

Financials

The company's recent financial performance has been a bit of a mixed bag. For the first-half FY21, the company reported top-line revenue growth of a touch over 30% versus the prior comparative period to €52.6 million ($81.2 million).

However, statutory earnings before interest, tax, depreciation and amortisation expenses (EBITDA) declined by 53.6% to $4.9 million and FINEOS reported a net loss after tax of $7.8 million, down from a net profit after tax of $0.15 million in first-half FY20.

The losses came due to an increase in operating expenses, which jumped 43.6% to $47.3 million. FINEOS acquired US-based insurance software company Limelight Health during the half for US$75 million. This increased personnel costs during the period due to the additional headcount brought over from Limelight.

Outlook

FINEOS reaffirmed its full-year outlook for revenue in the range of $157 million to $162 million. It will be hoping that it can keep its costs under control over the second half, or else shareholders may start to doubt the wisdom of the Limelight acquisition.

Even if the Limelight acquisition is revenue accretive, if that benefit is outweighed by ballooning personnel costs it may continue to drag on the company's bottom line growth.

Other recent news

In its first-half results announcement, FINEOS teased that it had signed a new client in the Australia and New Zealand region – which turned out to be New Zealand-based insurer Partners Life.

Following a "comprehensive market evaluation", Partners Life selected FINEOS' platform to process its insurance and medical claims. The deal is for a 5-year initial term.

Where next for the FINEOS share price?

FINEOS joins a growing list of COVID-19 market darlings – mostly technology companies – that enjoyed stellar share price growth last year but have run out of gas in 2021.

Companies like Bigtincan Holdings Ltd (ASX: BTH), Megaport Ltd (ASX: MP1) and Damstra Holdings Ltd (ASX: DTC) have all followed this pattern – with recent declines spurred by major selloffs on the tech-heavy NASDAQ index in the US.

It's hard to say where the FINEOS share price will head next. It already jumped as high as $4.75 earlier this month before dropping back down again. This level of volatility could be the new normal – at least over the short-term – as the market continues to try to work out what effect a post-COVID economic recovery might have on tech companies (like FINEOS) that actually grew during the pandemic.

Either way, all these tech companies are still worth watching closely this year – there could be some potential bargains available for opportunistic investors.

The post The FINEOS (ASX:FCL) share price is now 30% off its August highs appeared first on The Motley Fool Australia.

The FINEOS Corporation Holdings PLC (ASX: FCL) share price will be on watch tomorrow after the insurance software business released its FY21 half-year result. It also announced a new contract.

Why the FINEOS share price will be on the radar

The FINEOS share price will be in focus tomorrow after the company told investors its half-year revenue increased by 30.1% to €52.6 million. This was made up of 20.1% organic growth and 10% growth from acquisition.

Software revenue was €19.1 million. There was organic subscription recurring revenue growth of 35.1% year on year, or 51.5% growth including the contribution from a US acquisition called Limelight Health (LLH) which was acquired in August 2020. Initial license fee (ILF) revenue was down 16.8% to €1.5 million, reflecting a run off of the old pricing model revenue.

Services revenue was €33.4 million in the first half of FY21. There was organic services revenue growth of 15.9%, or 23.3% growth in the contribution from LLH.

Gross profit rose by 20.1% to €33.8 million.

The company reported that its underlying earnings before interest, tax, depreciation and amortisation (EBITDA) fell by 42.8% to €5.1 million and its statutory EBITDA fell 53.6% to €3.2 million.

FINEOS showed that there was a sizeable increase in its various spending categories including research and development (up 29.9%), sales and marketing (up 41.2%), cloud operations and support (up 434.7%) and general and administration (up 116.2%). The company explained that it continues to invest for growth and some of the expenses increased because of the higher headcount (up 40.8% to 1,043) after the LLH acquisition, as well as some one-off costs.

The company reported an underlying loss after tax of €2.5 million and a statutory net loss after tax of €5.1 million.  

Recent FINEOS share price movements

Over the last year the FINEOS share price is up around 15.7%. However, over the last six months the FINEOS share price has dropped almost 25%. 

FY21 outlook

FINEOS is expecting the FY21 revenue contribution to be in the range of €102 million to €105 million, after the foreign currency exchange impact.

The company reaffirmed its guidance of 30% growth in subscription revenue, that's before the contribution from LLH which is expected be approximately €4 million of subscription revenue in FY21.

The company also announced a new client in ANZ, representing the first in the region to feature on the FINEOS platform in the cloud.

New contract win

FINEOS said that Partners Life has selected the FINEOS platform for life insurance and medical claims after looking at a number of options.

The company said that the contract is a small-sized 5-year initial term software as a service (SaaS) contract. The expected revenue is already factored into the guidance.

Partners Life chief claims officer Tracey Lonergan said:

"It was important that the provider had the capability, experience and infrastructure to deliver and support a claims management system that would integrate into the Partners Life ecosystem. Also important to us was that the selected vendor come with a strong record of successful implementations and strong support of its claims management system within the New Zealand and Australian life and health insurance industry. FINEOS met those requirements. Our initial collaboration has been extremely positive, and we envisage that the project will deliver high quality results.

The post FINEOS (ASX:FCL) share price under spotlight with HY21 report, new contract win appeared first on The Motley Fool Australia.

There are some ASX shares that a number of brokers like and have rated as 'buys'

It can be quite hard to find good businesses that are trading at a good price. One investor might say that BHP Group Ltd (ASX: BHP) is a good buy, whilst another might say that Woolworths Group Ltd (ASX: WOW) is the share to buy.

Brokers are constantly looking at businesses and share prices, thinking about what would be a good investment. There are various brokers out there like Bell Potter, Macquarie Group Ltd (ASX: MQG) and UBS that provide different recommendations about shares.  

With that in mind, these ASX shares are liked by more than one broker. Of course, this still isn't a guarantee of success – they could all be herding together.

FINEOS Corporation Holdings PLC (ASX: FCL)

FINEOS is an ASX share liked by at least three brokers at the moment, including UBS which likes the tech company for the long-term growth opportunity.

This business says that it's a global player in the software space for the employee benefits and life, accident and health industry.

FINEOS operates a platform which has technology for a number of different areas for clients like new business, claims, policy, billing and absence. Its software is designed to manage the structure and relationships of group and individual insurance processing to optimise plan, coverage and data management, operational processing, and business intelligence.

The company is aiming to increase its market share over time. For the quarter ending 31 December 2020, FINEOS generated 69% growth of its cash receipts to €28.2 million.

City Chic Collective Ltd (ASX: CCX)

City Chic is an ASX share that's liked by at least three brokers, including Morgan Stanley.

It's a retailer of plus-size clothes, footwear and accessories for women. It operates through a number of different brands including Avenue, Evans, CCX, Hips & Curves and Fox & Royal.

This business isn't just a bricks and mortar operator in Australia and New Zealand. It's currently selling around 70% of its products online, with more than 40% of revenue being generated in the northern hemisphere.

City Chic recently acquired Evans in the UK. It's not taking over the retail store chain, but it is acquiring the online assets and the wholesale business. Those two segments generated £26 million of sales for the 12 months to August 2020. City Chic said that the retail store network had been shrinking in recent years as more customers transition to the digital channel. Evans bought this business for $41 million, funded from existing cash.

City Chic says that this acquisition will give the company a platform to launch in the $9 billion UK market. It's also confident that it can use its lean, customer-centric operating model to drive revenue growth and cost efficiencies in the existing business.

Brickworks Limited (ASX: BKW)

Brickworks is an ASX share that's liked by at least three brokers, including UBS.

The broker thinks that the housing industry has good growth potential in 2021 as long as there aren't any rate hikes or credit lending restrictions.

Brickworks has several different segments that serve the construction industry in Australia. It manufactures and sells bricks, paving, roofing, masonry, cement and precast.

The company also has its joint venture industrial property trust with Goodman Group (ASX: GMG) which is expected to increase in value significantly once the large warehouses for both Amazon and Coles Group Ltd (ASX: COL) are completed. The gross value of the trust's assets are expected to be higher than $3 billion once completed, which is also expected to lead to a 25% increase in the net rental profit distributions to Brickworks.

The post 3 ASX shares rated as strong buys by brokers appeared first on The Motley Fool Australia.

There are some ASX shares that a number of brokers like and have rated as 'buys'.

It can be quite hard to find good businesses that are trading at a good price. One investor might say that BHP Group Ltd (ASX: BHP) is a good buy, whilst another might say that Woolworths Group Ltd (ASX: WOW) is the share to buy.

Brokers are constantly looking at businesses and share prices, thinking about what would be a good investment. There are various brokers out there like Bell Potter, Macquarie Group Ltd (ASX: MQG) and UBS that provide different recommendations about shares.  

With that in mind, these ASX shares are liked by more than one broker. Of course, this still isn't a guarantee of success – they could all be herding together.

Alliance Aviation Services Ltd (ASX: AQZ)

This ASX share claims to be Australia's leading air charter operator, providing specialised services for the resources industry (fly in, fly out (FIFO)), and inbound and domestic group travel.

It's currently liked by at least three brokers, including Morgans. The broker likes a deal that Alliance recently revealed and Morgans thinks that the company can win further deals over time – supporting its decision to buy more planes.

The company recently signed a 'wet lease agreement' with Qantas Airways Limited (ASX: QAN) for the provision of Embraer E190 aircraft from the middle of 2021. Alliance said that the range and route economics make the E190 an attractive option in a post COVID-19 aviation market.

This agreement with Qantas initially provides for three E190 aircraft to commence operations in mid-2021, with options for Qantas to call on an additional 11 aircraft based on market conditions. The deal is for an initial period of three years. It will be for routes between Adelaide, Darwin and Alice Springs.

The deal is expected to account for more than 5% of total revenue once the first three aircraft have been fully deployed.

Reject Shop Ltd (ASX: TRS)

Reject Shop is an ASX share retailer, with a national footprint of discount stores across the country.

It's currently liked by at least three brokers.

The company is currently working on improving its cost base. It's looking at the rental costs across its store network and trying to negotiate with landlords. Management aren't afraid of closing stores if landlords won't lower costs.

Reject Shop is also reducing the number of different items (SKUs) that it sells. This is increasing its sales per SKU, it's increasing the buying power with suppliers and improving the stock managing ability of both its stores and distribution centres.

Once Reject Shop has reached its desired cost base, it will then grow its store network again and it's also exploring the idea of online sales.

FINEOS Corporation Holdings PLC (ASX: FCL)

FINEOS describes itself as a global software company for the employee benefits and life, accident and health industry.

The company's platform has software for a variety of areas including new business, claims, policy, billing and absence. Its software is designed to manage the structure and relationships of group and individual insurance processing to optimise plan, coverage and data management, operational processing, and business intelligence.

The ASX share is liked by at least three brokers, including Citi which believes that it is in a good position to increase its market share. Citi thinks that FINEOS' shares are trading at a good price and it's trading at a large discount to some of its ASX software share peers.

Citi has a share price target of $4.60 for FINEOS over 2021.

In the quarterly update for the three months to 31 December 2020, cash receipts were up 69% year on year to €28.2 million and it ended with €30.7 million of cash.

The post 3 ASX shares rated as strong buys by brokers appeared first on The Motley Fool Australia.